Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones

Biomarkers or mediators

Alessia Buglioni, John C Jr. Burnett

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Heart failure (HF) is a syndrome characterized by a complex pathophysiology which involves multiple organ systems, with the kidney playing a major role. HF can present with reduced ejection fraction (EF), HFrEF, or with preserved EF (HFpEF). The interplay between diverse organ systems contributing to HF is mediated by the activation of counteracting neurohormonal pathways focused to re-establishing hemodynamic homeostasis. During early stages of HF, these biochemical signals, consisting mostly of hormones and neurotransmitters secreted by a variety of cell types, are compensatory and the patient is asymptomatic. However, with disease progression, the attempt to reverse or delay cardiac dysfunction is deleterious, leading to multi-organ congestion, fibrosis and decompensation and finally symptomatic HF. In conclusion, these neurohormonal pathways mediate the evolution of HF and have become a way to monitor HF. Specifically, these mediators have become important in the diagnosis and prognosis of this highly fatal cardiovascular disease. Finally, while these multiple neurohumoral factors serve as important HF biomarkers, they can also be targeted for more effective and curative HF treatments.

Original languageEnglish (US)
Pages (from-to)3-8
Number of pages6
JournalClinica Chimica Acta
Volume443
DOIs
StatePublished - Mar 1 2015

Fingerprint

Biomarkers
Heart Failure
Hormones
Hemodynamics
Neurotransmitter Agents
Disease Progression
Homeostasis
Fibrosis
Cardiovascular Diseases
Chemical activation
Kidney

Keywords

  • Biomarkers
  • Cardiorenal axis
  • Heart failure
  • Mediators
  • Natriuretic peptides
  • RAAS

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones : Biomarkers or mediators. / Buglioni, Alessia; Burnett, John C Jr.

In: Clinica Chimica Acta, Vol. 443, 01.03.2015, p. 3-8.

Research output: Contribution to journalArticle

@article{1a3cefcfc38144b7b0d1c2a87085c5a7,
title = "Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: Biomarkers or mediators",
abstract = "Heart failure (HF) is a syndrome characterized by a complex pathophysiology which involves multiple organ systems, with the kidney playing a major role. HF can present with reduced ejection fraction (EF), HFrEF, or with preserved EF (HFpEF). The interplay between diverse organ systems contributing to HF is mediated by the activation of counteracting neurohormonal pathways focused to re-establishing hemodynamic homeostasis. During early stages of HF, these biochemical signals, consisting mostly of hormones and neurotransmitters secreted by a variety of cell types, are compensatory and the patient is asymptomatic. However, with disease progression, the attempt to reverse or delay cardiac dysfunction is deleterious, leading to multi-organ congestion, fibrosis and decompensation and finally symptomatic HF. In conclusion, these neurohormonal pathways mediate the evolution of HF and have become a way to monitor HF. Specifically, these mediators have become important in the diagnosis and prognosis of this highly fatal cardiovascular disease. Finally, while these multiple neurohumoral factors serve as important HF biomarkers, they can also be targeted for more effective and curative HF treatments.",
keywords = "Biomarkers, Cardiorenal axis, Heart failure, Mediators, Natriuretic peptides, RAAS",
author = "Alessia Buglioni and Burnett, {John C Jr.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.cca.2014.10.027",
language = "English (US)",
volume = "443",
pages = "3--8",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones

T2 - Biomarkers or mediators

AU - Buglioni, Alessia

AU - Burnett, John C Jr.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Heart failure (HF) is a syndrome characterized by a complex pathophysiology which involves multiple organ systems, with the kidney playing a major role. HF can present with reduced ejection fraction (EF), HFrEF, or with preserved EF (HFpEF). The interplay between diverse organ systems contributing to HF is mediated by the activation of counteracting neurohormonal pathways focused to re-establishing hemodynamic homeostasis. During early stages of HF, these biochemical signals, consisting mostly of hormones and neurotransmitters secreted by a variety of cell types, are compensatory and the patient is asymptomatic. However, with disease progression, the attempt to reverse or delay cardiac dysfunction is deleterious, leading to multi-organ congestion, fibrosis and decompensation and finally symptomatic HF. In conclusion, these neurohormonal pathways mediate the evolution of HF and have become a way to monitor HF. Specifically, these mediators have become important in the diagnosis and prognosis of this highly fatal cardiovascular disease. Finally, while these multiple neurohumoral factors serve as important HF biomarkers, they can also be targeted for more effective and curative HF treatments.

AB - Heart failure (HF) is a syndrome characterized by a complex pathophysiology which involves multiple organ systems, with the kidney playing a major role. HF can present with reduced ejection fraction (EF), HFrEF, or with preserved EF (HFpEF). The interplay between diverse organ systems contributing to HF is mediated by the activation of counteracting neurohormonal pathways focused to re-establishing hemodynamic homeostasis. During early stages of HF, these biochemical signals, consisting mostly of hormones and neurotransmitters secreted by a variety of cell types, are compensatory and the patient is asymptomatic. However, with disease progression, the attempt to reverse or delay cardiac dysfunction is deleterious, leading to multi-organ congestion, fibrosis and decompensation and finally symptomatic HF. In conclusion, these neurohormonal pathways mediate the evolution of HF and have become a way to monitor HF. Specifically, these mediators have become important in the diagnosis and prognosis of this highly fatal cardiovascular disease. Finally, while these multiple neurohumoral factors serve as important HF biomarkers, they can also be targeted for more effective and curative HF treatments.

KW - Biomarkers

KW - Cardiorenal axis

KW - Heart failure

KW - Mediators

KW - Natriuretic peptides

KW - RAAS

UR - http://www.scopus.com/inward/record.url?scp=84924239991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924239991&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2014.10.027

DO - 10.1016/j.cca.2014.10.027

M3 - Article

VL - 443

SP - 3

EP - 8

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -